Coronavirus Flash Update: August 3, 2020

Alston & Bird’s Coronavirus Flash provides updates on policy and regulatory actions under consideration across many important industries being monitored by our teams. Links to key government and legal resources are provided throughout the report.

Click here to view coronavirus-related News & Insights. Subscribe for updates.  

UPDATED 9:00 AM ET ON MONDAY, AUGUST 3, 2020

The Latest News

• U.S. COVID-19 cases exceed 4,641,690 and 154,002 U.S. deaths. (Source: CDC) (Updated 8/3/20)
• U.S. stock market: On Friday the major benchmarks all posted gains for the day, with the Dow rising 114 points, the S&P 500 gaining 24 points, and the Nasdaq adding 157 points. (New)
• The Senate Republican leadership released the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act on July 27, a $1 trillion emergency relief proposal and a counter to the House passed (May 15) HEROES Act. The initial negotiations centered on the expiring $600 supplemental unemployment benefit in an unsuccessful effort to reach a consensus before it expired on July 31. Discussions continue on the unemployment benefit as well as other areas of significant differences, including liability protection. Little progress appears to have been made over the weekend in the stimulus package discussions even as the leadership of both bodies agree that something must be enacted before they depart for the Presidential party conventions during the last two weeks of the month. (New)
• The HEALS Act was released as a compilation of separate bills sponsored by various GOP Senators: (New)
  • Liability protections, 4317, “SAFE to WORK Act”
  • Finance Committee bill, 4318, “American Workers, Families and Employers Assistance Act”
  • Business meals deduction, 4319 ,“Supporting America's Restaurant Workers Act”
  • Appropriations, 4320, “Coronavirus Response Additional Supplemental Appropriations Act, 2020”
  • Small business provisions, 4321, “Continuing Small Business Recovery and Paycheck Protection Program Act”
  • HELP Committee bill,  4322, “Safely Back to School and Back to Work Act”
  • Trust fund solvency, 4323, “TRUST Act of 2020”
  • 4324, “Restoring Critical Supply Chains and Intellectual Property Act” (including the “US Made Act”)

COVID-19 Federal Legislation   

• Bill 4.0:
• The HEALS Act was released in sections by the authorizing committees: (New)
  • Senate Finance, S. 4318: Text, Section-by-Section
  • Senate Liability Protections, S. 4317: Text
  • Senate Small Business, S. 4321: Text, Section-by-Section
  • Senate Appropriations Health, Education, and Labor : Section-by-Section
  • Senate Appropriations Supplemental, S. 4320: Text, Section-by-Section
  • Senate Trust Funds, S. 4323: Text, Section-by-Section
  • Senate HELP – Education: Section-by-Section
  • Senate HELP – Education School Choice, S. 4322: Text, Summary
  • Senate Supply Chain, S. 4324: Text
  • Senate Restaurant Workers, S. 4319: Text
• The HEROES Act was the first formal offer on a new emergency stimulus bill, 4.0: For the full details on the HEROES Act, H.R. 6800, which passed the House on May 15:
  • The HEROES Act text is available here.
  • A 1-pager and 71 page section-by-section summary are available here.
  • And an outline of the state and local funding provisions is here.
• The Paycheck Protection Flexibility Act, H.R. 7010, was enacted on June 5. To learn more, see this A&B Summary of the Paycheck Protection Flexibility Act. (6/5/20)
• Bill 3.5: Paycheck Protection Program and Health Care Enhancement Act, (R. 266) was enacted on April 24. Also available are a section-by-section summary and an overview of the health care provisions.
• A&B detailed summaries are below:
  • A&B Summary – 5 Small Business Provisions
  • A&B Summary – 5 Health Care Enhancement Provisions
• Bill 3.0: Coronavirus Aid, Relief, and Economic Security (CARES) Act, (R. 748) passed on March 27. A congressional section by section summary is available here.
• Congress has passed three coronavirus emergency response bills and the first two are below:
• Bill 1.0: Coronavirus Preparedness and Response Supplemental (CPPRS) (R. 6074) passed on March 5
• Bill 2.0: Families First Coronavirus Response Act (FFCRA) (R. 6201) passed on March 18

Transition to “Reopening”   

• Administration Actions
• The Administration released a set of guidance targeting the reopening of schools and a resource website. (Updated 7/24/20)
  • The Department of Commerce Economic Development Administration announced $7.8 million in aid to universities to assist in their recovery and reopening. (7/31/20) (New)
  • The Environmental Protection Agency (EPA) approved 13 products on List N to be used as effective disinfectants against COVID-19. (7/30/20) (New)
  • The CDC updated or released guidance for reopening:
  • Hiring In-Home Services or Repairs (7/30/20) (New)
  • How To Clean and Disinfect a Facility (7/29/20) (New)
  • Businesses and Workplaces (Updated 7/28/20)
  • Worker Safety and Support (Updated 7/28/20)
• State/Other Actions
  • For the latest information on state reopening decisions, see A&B 50-State Reopening - updated in each A&B Coronavirus Flash. (Updated 7/30/20)

Department of Health and Human Services   

• HHS has a tracking feature that allows public viewing of all COVID-19 HHS grants and cooperative agreement awards on its website. The grants were distributed through programs in the ACF, ACL, ASPR, CDC, DHHS/OS, HRSA, IHS, NIH, and SAMHSA. (Updated 7/30/20)
• The National Institutes of Health announced an investment in 7 companies for new testing technologies. (7/31/20) (New)
• The HHS Office of Assistant Secretary of Preparedness and Response (ASPR) released a Lessons Learned document for Urgent Care Centers and the treatment of COVID-19. (7/30/20) (New)
• ASPR released a report on staffing considerations for crisis standards of care. (7/30/20) (New)
• ASPR releases a table on the allocation and distribution of remdesivir. (7/30/20) (New)
• HHS released a report showing the trends in Medicare beneficiary telehealth utilization during COVID-19. (7/29/20) (New)
• HHS has created a new public data website as a COVID-19 Resource. (7/26/20)
• HHS and the Department of Defense announced:
• Joint agreement with Sanofi and GSK on commercial-scale manufacturing project to produce COVID-19 investigational vaccine doses. (7/31/20) (New)
• Joint agreement with Becton, Dickinson and Company to establish and expand production of SARS-CoV-2 Assays for BD Veritor Devices. (7/31/20) (New)

HHS/CDC/CMS/HRSA CARES Act Provider Relief Funds   

• HHS - the CARES Act Provider Relief Fund (PRF) webpage (Updated 7/17/20)
• And the PRF FAQs (Updated 7/30/20) have been updated and capture numerous modifications.
• The CDC has posted an updated dataset of provider recipient specific payment from the Provider Relief Fund general distribution high impact targeted allocation and/or rural targeted allocation. The dataset includes who has attested to receiving one or more payments and agreed to the terms and conditions as of July 30. (Updated 7/30/20)
• A&B Hospital Provisions in all 4 bills tracker (Updated 8/2/20)
• A&B Provider Relief Fund Disbursements tracker (Updated 8/2/20)

Centers for Disease Control and Prevention  

• The Centers for Disease Control and Prevention (CDC) COVIDView Weekly Summary is available. (Updated 7/31/20)
• The CDC weekly COVID forecast. (Updated 7/29/20)
• The CDC S. testing data. (Updated 8/2/20)
• The CDC FAQs on testing for SARS-CoV-2. (Updated 7/31/20)
• CDC webpage for all COVID-19 toolkits, videos, print resources, PSAs, FAQs and web resources. (Updated 7/31/20)
• CDC updated its FAQs for laboratories. (Updated 8/2/20)
• CDC electronic laboratory reporting map. (Updated 7/30/20)
• CDC information for laboratories required to report to state and local public health authorities. (Updated 7/31/20)
• The CDC released a series of public service announcements to increase donation of convalescent plasma in the treatment of COVID-19. (7/30/20) (New)
• The CDC has released new guidance for:
• COVID-19 Antibody Testing (Updated 7/30/20)
• Transferring Patients to Balance Care at Healthcare Facilities (7/30/20) (New)
• Preparedness Tools for Healthcare Professionals and Facilities (7/30/20) (New)
• Contact Tracing Documents (Updated 7/30/20)
• Rural Communities (Updated 7/30/20)
• Data on COVID-19 During Pregnancy (Updated 7/30/20)
• HIV and COVID-19 (Updated 7/29/20)

Centers for Medicare & Medicaid Services  

• The Centers for Medicare and Medicaid Services (CMS) latest news alerts. (Updated 7/31/20)
• For the latest COVID-19 related CMS guidance and FAQs visit the CMS Current Emergencies webpage. (Updated 7/30/20)
• CMS jointly with the CDC announced that payment is available to physicians and health care providers to counsel patients related to self-isolation and other steps related to COVID-19 self-care. A Provider Q&A is also available. (7/30/20) (New)
• CMS announced new therapeutic procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19. (7/30/20) (New)
• CMS released its first monthly update of data COVID-19 and the Medicare population. (7/29/20) (New)

Food and Drug Administration   

• FDA provides a daily roundup on COVID-19 related actions. (Updated 7/31/20)
  • FDA updated its FAQs on Testing for SARS-CoV-2 relating to the development and performance of tests for SARS-CoV-2. (Updated 7/24/20)
  • FDA maintains its COVID-19 FAQs for the general public. (Updated 7/24/20)
  • FDA webpage for health professionals. (Updated 7/16/20)
  • The agency also maintains a public database of drug shortages. (Updated 7/24/20)
  • FDA webpage on Coronavirus Treatment Acceleration Program (CTAP) (Updated 7/14/20)
• The FDA issued a warning letter for fraudulent COVID-19 products to:
• Vapore LLC dba Mypurmist (7/31/20) (New)
• The FDA authorizes the first tests that estimate a patient’s antibodies from past SARS-CoV-2 infection. (7/31/20) (New)
• The FDA FAQs on Antibody (Serology) testing: Information for Patients and Consumers. (Updated 7/29/20)
• The FDA posts a new template for At-Home and Over-the-Counter diagnostic tests for use in non-lab settings such as homes, schools, and businesses. (7/29/20) (New)
• The FDA reiterates its warnings about certain alcohol-based hand sanitizers. (7/27/20) (New)
• The FDA issued emergency use authorization (EUAs) for: (New)
• Eli Lilly and Company for its Lilly SARS-CoV-2 Assay
• Sandia National Laboratories for its SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay
• Xiamen Biotime Biotechnology Co., Ltd., for its BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test
• Access Bio, Inc., for its CareStart COVID-19 IgM/IgG
• The FDA issued the first diagnostic test for screening of people without known or suspected COVID-19. (7/24/20) (New)

Small Business Administration   

• The President signed into law 4116 which reauthorizes the Paycheck Protection Program (PPP) through August 8. (7/4/20)

Other Federal Agencies

• The Department of Education announced $180 million in grants to 11 states for education response during the pandemic. (7/29/20) (New)
• The U.S. International Development Finance Corporation announced a $765 million loan to Kodak under the Defense Production Act to boost domestic manufacturing of drugs. (7/28/20) (New)
• The Department of Transportation announced $273 million in grants to 184 airports. (7/28/20) (New)
• The Department of Treasury announced it had reached an agreement with the United States Postal Service on terms for a CARES Act loan of up to $10 billion. (7/29/20) (New)

For background and the most up-to-date information, please visit the Centers for Disease Control and Prevention Coronavirus Disease 2019 website: HERE. The additional federal agency links are provided by the White House Coronavirus Task Force:   What You Should Know:

• How to Protect Yourself & Others
• What to Do If You Are Sick with COVID-19
• Symptoms
• Facts about COVID-19
• Guidance Documents

Information for Businesses:

• Information for Communities, Schools, and Businesses
• Workplaces during the COVID-19 Pandemic
• Cleaning and Disinfecting Your Facility
• Worker Safety and Support
• COVID-19 Critical Infrastructure Sector Response Planning
• General Business Frequently Asked Questions
• Information for Small Businesses
• SBA: COVID-19 Resources
• Treasury: Assistance for Small Businesses
• DOL: Guidance for Preparing Workplaces for Coronavirus
• DOL: COVID-19 and the American Workplace
• DOL: OHSA Resources for Workers and Employers on COVID-19
• WHO: Get Your Workplace Ready for COVID-19
• CISA: Risk Management for COVID-19
• CISA: Telework Guidance and Resources
• CISA: Guidance on the Essential Critical Infrastructure Workforce

Information for Travel and Transportation:

• Information for Travel
• Travel in the United States
• Public Health Considerations for Reopening Mass Transit During the Covid-19 Pandemic
• COVID-19 Travel Recommendations by Country
• Travel Restrictions to Prevent the Spread of Disease
• Airline Guidance
• Cargo Ship Guidance
• Maritime Resources
• Returning from International Travel
• Travelers Returning from Cruise Ship and River Cruise Voyages
• Travel: Frequently Asked Questions and Answers
• Travelers Prohibited from Entry to the United States
• Communication Resources for Travelers
• State: Travel Advisories
• State: Traveler’s Checklist
• State: Smart Traveler Enrollment Program
• DOT: FAQs from FTA Grantees Regarding COVID-19
• DOT: Expanded Emergency Declaration
• FAA: Guidance for Air Carriers and Crews

Alston & Bird Coronavirus Links

• Alston & Bird Coronavirus Response & Relief Web page
• To Subscribe to Alston & Bird Advisories
• For Alston & Bird COVID-19 Insights and Events
• Previous Alston & Bird Coronavirus Advisories (not included in the above)
• July 15
  • Labor & Employment Advisory: DHS Reverses Course - International Students Allowed to Continue Studies and Employment in the U.S.
• July 9
  • “COVID-19 Will Have Lasting Impact on Construction Contracts,” Law360
• July 6
  • Finance Advisory: COVID-19 Update - What Your Business Needs to Know About the Corporate Governance and Insolvency Act of 2020
• July 2
  • Environment, Land Use & Natural Resources Advisory: EPA Modifies Guidance for Compliance During the COVID-19 Pandemic
• July 1
  • “What COVID-19 Means for the Future of Health Mergers,” Law360
• June 30
  • Securities Law Advisory: When In Doubt, SEC Wants You to Consider COVID-19 Disclosures
• June 15
  • International Tax Advisory: Who Says You Can’t Go Home? IRS Sends Care Package to Those Away From Home Due to COVID-19
• June 8
  • Into the Unknown: Employee Retention Credits Remain Murky
• June 5
  • Environmental, Land Use & Natural Resources Advisory: President Issues Executive Order on Expediting Infrastructure Investments
  • What’s in Store: A&B Review of the Challenges for Retailers During COVID-19
• June 3
  • Grand Reopening: Guidelines for Resuming Business Operations in California Amid COVID-19
• June 1
  • Federal Tax Advisory: Disaster Losses
• May 29
  • Environment, Land Use & Natural Resources Advisory: Emergency Rule 9 Amendment Provides Deadlines for Statutes of Limitations
• May 22
  • A&B Environment and Land Use Briefing: COVID-19 Articles Included
• May 21
  • Prescribing Paid Sick Leave -- An Important Tool for Primary Care During the Pandemic: JAMA Health Forum
• May 18
  • International Tax Advisory: Proposed Treasury Regulations Clarify UBTI “Silo” Rule
  • Financial Services Litigation / Financial Services & Products Advisory: CFPB Reflects on the Impact of COVID-19 and Provides a Window into Future Enforcement
• May 15
  • A&B Investment Management Updates, including items reflecting the impact of the coronavirus pandemic.
• May 12
  • Finance Advisory: Ginnie Mae Extends PTAP/C19 Assistance to Multifamily MBS Program
  • A&B Guide to Telehealth Waivers and Regulatory Flexibilities
  • The Digital Download -- Alston & Bird’s Privacy & Data Security Newsletter
• May 8
  • Finance Advisory: ESG During the Coronavirus Crisis -- Should You Care?
  • Health Care / Privacy & Data Security Advisory: Expansive Interoperability and Data-Sharing Requirements Require Attention Despite Delays in Enforcement
  • Financial Restructuring & Reorganization Advisory: Delaware Courts Leery of Shareholder Obstruction
• May 6
  • Finance Advisory: Federal Reserve Revises Main Street Lending Program, Adds Third Option
• May 5
  • Finance Advisory: Brexit and Its Potential Impact on Cross-Border Litigation Throughout Europe
  • Investment Management Advisory: Update on Relief Under the CARES Act for Fund Managers
• May 4
  • Food, Drug & Device/FDA Advisory: Examining the Drug Supply Chain -- How the Public Health Emergency Impacts DSCSA
• April 30
  • College & Universities Advisory: Schools Face Class Action as Parents and Students Sue for Refunds
  • White Collar Government & Internal Investigations Advisory: New PPP Funding Ups Ante for Compliance Failure--Audits on the Horizon
• April 29
  • Health Care / Health Care Litigation Advisory: COVID-19 A Tipping Point for Telehealth Expansion
• April 28
  • Labor & Employment Advisory: The New Executive Order Suspends Entry of Immigrant Visa Applicants into the U.S. for 60 days
• April 24
  • Commercial Litigation Advisory: COVID-19 Impacts on Statutes of Limitations
• April 23
  • International Trade & Regulatory Advisory: FEMA Issues Guidance on Exemptions for Critical PPE Export Restrictions
• April 22
  • Labor & Employment Advisory: Developing a Plan to Bring Your Employees Back to Work
• April 21
  • Financial Advisory: Forbearance Agreements in the age of COVID-19 and National Shelter-in-Place Orders
  • Antitrust / Mergers & Acquisitions / International Trade & Regulatory Advisory: COVID-19 Affect European Foreign Direct Investment Reviews: New EU Guidance Potentially Heralds Increased Protectionism
• April 20
  • Financial Advisory: FHFA Limits Servicer Advancing Obligations for Loans in COVID-19 Forbearance
• April 17
  • “INSIGHT: Businesses Better Brace for Post-Coronavirus Lawsuits” Bloomberg Law
  • Antitrust / Labor & Employment Advisory: Federal Antitrust Agencies Remind Businesses That Colluding on Labor Issues Remains Illegal During Pandemic
  • Labor & Employment / Health Care / Corporate & Finance Advisory: Ramping Up: What Does Restarting Look Like?
• April 16
  • International Tax Advisory: Risky Business - Allocating Losses When Your Supply Chain Is Disrupted
  • Finance Advisory: Ginnie Mae Expands Pass-Through Assistance Program to Finance Servicing Advances in Response to COVID-19
• April 15
  • “Force Majeure Clauses in the Face of COVID-19: Commercial Leasing Guidance (CA),” Lexis Practice Advisor
  • Federal Tax Advisory: IRS Issues COVID-19 Forbearance Guidance for REMICs and Investment Trusts
• April 14
  • Investment Advisory: Federal Reserve Announces Main Street Lending Program to Provide Liquidity to Small & Mid-Size Businesses
  • Investment Management Advisory: Relief Under the CARES Act for Fund Managers
• April 13
  • “As Pandemic Triggers Continuity Plans, What RIAs and BDs Should Ask Themselves,” Financial Planning
  • FDA & Environment Advisory: Cleaning Up After COVID-19? What You Need to Know Before You Manufacture, Import, or Sell Sterilizers, Sanitizers, Purifiers, and Disinfectants
  • Securities Law Advisory: SEC Reminds Companies to Keep Their Disclosures Looking Forward
• April 10
  • Securities Law Advisory: ISS Offers COVID-19-Conscious Policy Guidance
• April 9
  • Federal Tax Advisory: IRS Provides Partnerships a Mechanism to Claim Benefit of Retroactive CARES Act Provisions
  • Financial Services Advisory: Agencies Update Their Interagency Statement on Reporting Loan Modifications
  • Early Securities Class Actions Highlight COVID-19 Litigation Risk (Law360)
  • FDA Compliance & Enforcement Advisory: FDA Issues New Guidance on Supply-Chain Disruption Notifications During COVID-19 Emergency
  • Financial Restructuring & Reorganization Advisory: Protecting Recoveries in a Pandemic: What Creditors Can Do Right Now
• April 7
  • Updated FAQs Regarding Paid Leave Obligations Under the Families First Coronavirus Response Act
  • Cyber Alert: Cybersecurity and COVID-19: Four Categories of Cyber Threats and Practical Tips in Response
• April 6
  • Antirust Advisory: Production and R&D Joint Ventures in a Pandemic: Reducing Antitrust Risk
  • Financial Services Advisory: Regulatory Agencies Issue Mortgage Servicing Guidance and FAQs for the CARES Act
  • White Collar, Government Investigations Advisory: CARES Act Follows Familiar Blueprint for Oversight and Enforcement
• April 3
  • EU State Aid Measures in the Fight Against COVID-19 Pandemic
• April 2
  • USPTO Announces Additional Limited Extensions Due to the COVID-19 Pandemic
  • Deadline for Reg BI and Form CRS Compliance Remains on Track
  • What Does the Coronavirus Mean for Companies and Their Critical Offshore Services?
• April 1
  • Federal Tax Advisory: Downward Stock Attribution for CFC Purposes
  • Hospital EMTALA Obligations Under Recent COVID-19 Waivers
  • CMS Issues Blanket Waivers from Physician Self-Referral Law Sanctions
• March 31
  • Additional Families First Coronavirus Response Act Paid Leave FAQs for Employers
  • SEC Extends Timeframe for Regulatory Relief for Investment Advisers and Investment Companies
  • Responsibility for Construction Site Safety in a Coronavirus World
• March 30
  • Keep Mystery to a Minimum in Your SEC COVID-19 Disclosures
  • How the CARES Act Will Affect Banking During the Coronavirus Emergency
  • Economy in Chaos: Is Bankruptcy Inevitable for My Business?
  • CMS Announces Expansion of Medicare’s Accelerated and Advance Payment Program
• March 27
  • Utilization of Electronic Signatures and Records: What You Need to Know
  • SEC Extends Conditional Filing Relief to Companies Affected by COVID-19
  • COVID-19: What It May Mean for Landlords and Lenders Under Their CRE Facility Agreements
  • Congress Further Expands Medicare Telehealth Benefits with the CARES Act
• March 26
  • USTR to Consider Additional Tariff Exclusions Due to COVID-19 Pandemic
  • COVID-19 and Price Gouging
  • SEC Continues to Keenly Monitor Insider Trading During COVID-19 Pandemic
• March 25
  • Is the COVID-19 Outbreak an “Act of God”? Why It May Matter for Your Contracts
  • FDA and USDA Food Safety Response to COVID-19 & DHS “Critical Infrastructure” Classification of Food and Agriculture Sector
  • Does Your Force Majeure Provision Extend to the Coronavirus?
  • Competition Authorities Across Europe Relax Competition Law Enforcement During COVID-19 Outbreak
  • COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
• March 24
  • Health Care Providers with Exposure to COVID-19: What You Need to Know
  • Regulators Further Clarify Guidance Regarding Loan Modifications and Reporting
  • Avoiding Antitrust Risk as Industries Respond to the Coronavirus: Businesses Look to Collaborate & Federal Government Offers Expedited Avenues
• March 23
  • FDA Continues to Accelerate Availability of COVID-19 Tests
  • CFTC Issues No-Action Letter Offering Regulatory Relief for CPOs
  • Building a Case for Force Majeure in Construction Contracts
• March 20
  • Employee Benefits & Executive Compensation Advisory: Coronavirus Impact on Health Benefits: A Deeper Dive
  • FDA Compliance & Enforcement Advisory: FDA Temporarily Postpones Routine Domestic Inspections
• March 19
  • Antitrust / Mergers & Acquisitions Advisory: COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
  • Construction Advisory: Five Best Practices for Construction Industry Stakeholders During the Coronavirus Pandemic
  • Labor & Employment Advisory: Employee Leave Requirements Under the Families First Coronavirus Response Act
  • Labor & Employment / Health Care Advisory: Coronavirus (COVID-19) FAQs for Employers
• March 18
  • Cyber Alert: Six Practical Tips for Practicing Cyberhygiene in the Middle of a Global Pandemic
  • Advisory: Are You an “Essential Business” in California Counties Where Shelter-in-Place Order Have Been Issued?
• March 17
  • Finance Advisory: Coronavirus and Securitization: Disclosure and Diligence Issues
• March 16
  • Securities Law Advisory: SEC Provides Guidance on the Possible Impacts of COVID-19 on Annual Meetings
  • Health Care / Cybersecurity Preparedness & Response Advisory: COVID-19 and HIPAA: Privacy, Security, and Breach Response During a Global Pandemic
• March 13
  • Financial Services & Products Advisory: FINRA Guidance: COVID-19 and Business Continuity Planning
  • Food, Drug & Device/FDA Advisory: FDA Seeks Help to Solve Personal Protective Equipment Shortages
  • Securities Litigation Advisory: Securities Litigation Risk Arising Out of the Coronavirus Pandemic
• March 12
  • FDA Compliance & Enforcement Advisory: FDA Postpones Foreign Inspections Through April 2020: Considerations for Industr
• March 10
  • Labor & Employment / Health Care Advisory: Coronavirus, Employers, and Domestic Travel: A Complicated Business Decision
• March 6
  • Securities Law Advisory: SEC Provides Conditional Relief to Companies Affected by COVID-19
• March 5
  • Health Care Advisory: Congress Expands Medicare Telehealth Benefit Amid Coronavirus Concerns
• February 28
  • Labor & Employment / Health Care Advisory: The Coronavirus: Employer and Workplace Consideration